Attwill Accelerator

Taking biotech from paper to packaging

Attwill Accelerator empowers startups and researchers to take their ideas out of the lab

We provide scalable manufacturing solutions and funding opportunities to promising ideas and their advocates. Combining our regulatory expertise with years of experience managing public and private biotech companies, the Attwill team works to bring your innovative ideas to the public.



Brand Development

We work with our marketing partners and trademark team to make your product stand out and maximize its reach.


Marketing Deployment

Attwill can leverage its marketing and distribution network to get your new product onto shelves and into hospitals.


R&D Team

Our world-class research scientists and engineers have experience working with pharmaceuticals, biologics, medical devices, and nutraceuticals. They can help perfect your product for final release.



The regulatory process can be both grueling and daunting. Our regulatory team will help find the optimal regulatory pathway to make it a little easier.


Scale Up

Attwill has production facilities for milligram-to-ton volumes. We’re ready to take you from one of that scale to the other and help fund the trip.


Quality Systems

Our quality systems were developed over decades of manufacturing excellence and undergo regular audits confirming their effectiveness. Production consistency and efficiency are of utmost importance.

Join Attwill’s growing family of biotech ventures

Adventa BioScience

An innovative biotech firm dedicated to developing a series of products that realize the full potential of human milk.


Trulacta is the first supplement to contain Human Milk Bionutrients™ (HMBs™), the rich multitude of beneficial nutrients contained in human milk. Those proteins, fats, vitamins and carbohydrates are proven to be essential for human health and well-being. When taken daily, Trulacta supports gastrointestinal and whole-body health.

Anti-thrombin Heparin (ATH)

Anti-thrombin Heparin (ATH) technology is a breakthrough heparin formulation that reduces the risk of blood clots and unwanted thrombosis in catheters and other medical devices, but is safer and more active than other Heparin on the market. ATH is a connector device that delivers novel antithrombin and heparin (anticoagulant) into the inner lumen of catheters during the locking of catheters.

Talk to us about your product idea.

Interested in pitching to Attwill? Let us hear from you using the form below.